EVALUATING NEONATAL OUTCOMES IN PREGNANCIES COMPLICATED BY MATERNAL TYPE 2 DIABETES

F ARA; QUA QURESHI; M MANSOOR; M SHOAIB; S BIBI; SQ JAVED

doi:10.54112/bcsrj.v2024i1.1301

Authors

F ARA Department of OBG Unit 1 Bolan Medical College Quetta Sandeman Provincial Hospital Quetta, Pakistan
QUA QURESHI Department of Obstetrics and Gynecology Unit II, Liaquat University of Medical Health Sciences, Jamshoro, Sindh, Pakistan
M MANSOOR Department of Diagnostic Radiology Bolan Medical College Quetta, Pakistan
M SHOAIB Department of Gynae Unit 1 Sandeman Provincial Hospital Quetta, Pakistan
S BIBI Department of Gynae Bolan Medical College Quetta, Pakistan
SQ JAVED Department of Obstetrics & Gynecology Ruwaidah General Hospital Moh, KSA

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1301

Keywords:

Maternal Type 2 Diabetes, Neonatal Outcomes, Glycemic Control, Macrosomia, Neonatal Hypoglycemia, Congenital Anomalies, NICU Admissions

Abstract

Maternal type 2 diabetes during pregnancy presents complex challenges that necessitate careful management due to its multifaceted impacts on both the mother and the neonate. Objective: The basic aim of the study is to find the neonatal outcomes in pregnancies complicated by maternal type II diabetes. Methods: This retrospective observational study was conducted at Sandeman Provincial Hospital from April 2022 to March 2023. Data were collected from 80 participants. Data were collected retrospectively from medical records, focusing on maternal, fetal, and neonatal parameters. Maternal records included demographic details such as age, body mass index (BMI), and parity, as well as clinical information on glycemic control measured by HbA1c levels recorded at various points throughout the pregnancy. Results: Data were collected from 80 patients with type 2 diabetes, with an average maternal age of 32.35 years and an average BMI of 28.5 kg/m². Primiparous women constituted 40% of the sample. The average HbA1c level was 7.5%, with 56.25% of participants achieving good glycemic control (HbA1c ≤ 7%) and 43.75% classified as having poor glycemic control (HbA1c > 7%). The results indicate that the average neonatal birth weight was 3,400 ± 500 grams. Macrosomia was observed in 31.25% of cases, with a significantly higher occurrence in the poor glycemic control group (51.4%) compared to the good glycemic control group (15.6%). Conclusion: It is concluded that poor glycemic control in pregnancies complicated by maternal type 2 diabetes is significantly associated with adverse neonatal outcomes, including macrosomia, neonatal hypoglycemia, congenital anomalies, and higher NICU admission rates.

Downloads

Download data is not yet available.

References

Alshomrany, Abdullah, Elhadi Miskeen, Jaber Alfaifi, Hassan Alshamrani, and Abdulmohsen Alshahrani. 2024. "Maternal Diabetes Mellitus and Neonatal Outcomes in Bisha: A Retrospective Cohort Study" Medical Sciences 12, no. 2: 21. https://doi.org/10.3390/medsci12020021

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda BI. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.

American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Suppl. S1)–S33.

Prakash GT, Das AK, Habeebullah S, Bhat V, Shamanna SB. Maternal and neonatal outcome in mothers with gestational diabetes mellitus. Indian J Endocrinol Metab. 2017;21:854.

Gojnic M, Todorovic J, Stanisavljevic D, Jotic A, Lukic L, Milicic T, et al. Maternal and fetal outcomes among pregnant women with diabetes. Int J Environ Res Public Health. 2022;19:3684.

Alsaedi SA, Altalhi AA, Nabrawi MF, Aldainy AA, Wali RM. Prevalence and risk factors of gestational diabetes mellitus among pregnant patients visiting National Guard primary health care centers in Saudi Arabia. Saudi Med J. 2020;41:144.

Wahabi H, Fayed A, Esmaeil S, Mamdouh H, Kotb R. Prevalence and complications of pregestational and gestational diabetes in Saudi women: Analysis from Riyadh Mother and Baby cohort study (RAHMA). Biomed Res Int. 2017;2017:6878263.

Gualdani E, Di Cianni G, Seghieri M, Francesconi P, Seghieri G. Pregnancy outcomes and maternal characteristics in women with pregestational and gestational diabetes: A retrospective study on 206,917 singleton live births. Acta Diabetol. 2021;58:1169–76.

Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Ramezani Tehrani F. The impact of diagnostic criteria for gestational diabetes on its prevalence: A systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:11.

Anjum SK, Yashodha HT. A study of neonatal outcome in infants born to diabetic mothers at a tertiary care hospital. Int J Contemp Pediatr. 2018;5:489–92.

Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, et al. Diabetes and pregnancy: National trends over a 15 year period. Diabetologia. 2018;61:1081–8.

Ali DS, Davern R, Rutter E, Coveney C, Devine H, Walsh JM, et al. Pre-gestational diabetes and pregnancy outcomes. Diabetes Ther. 2020;11:2873–85.

Seghieri G, Di Cianni G, Seghieri M, Lacaria E, Corsi E, Lencioni C, et al. Risk and adverse outcomes of gestational diabetes in migrants: A population cohort study. Diabetes Res Clin Pract. 2020;163:108128.

Muche AA, Olayemi OO, Gete YK. Effects of gestational diabetes mellitus on risk of adverse maternal outcomes: A prospective cohort study in Northwest Ethiopia. BMC Pregnancy Childbirth. 2020;20:73.

Kruit H, Mertsalmi S, Rahkonen L. Planned vaginal and planned cesarean delivery outcomes in pregnancies complicated with pregestational type 1 diabetes–A three-year academic tertiary hospital cohort study. BMC Pregnancy Childbirth. 2022;22:173.

Magro-Malosso ER, Saccone G, Chen M, Navathe R, Di Tommaso M, Berghella V. Induction of labour for suspected macrosomia at term in non-diabetic women: A systematic review and meta-analysis of randomized controlled trials. BJOG. 2017;124:414–21.

Bayoumi MA, Masri RM, Matani N, Hendaus MA, Masri MM, Chandra P, et al. Maternal and neonatal outcomes in mothers with diabetes mellitus in Qatari population. BMC Pregnancy Childbirth. 2021;21:651.

Li MF, Ma L, Yu TP, Zhu Y, Chen MY, Liu Y, et al. Adverse maternal and neonatal outcomes in pregnant women with abnormal glucose metabolism. Diabetes Res Clin Pract. 2020;161:108085.

Silva AL, Amaral AR, Oliveira DS, Martins L, Silva MR, Silva JC. Desfechos neonatais de acordo com diferentes terapêuticas do diabetes mellitus gestacional. J Pediatr. 2017;93:87–93.

Yang GR, Dye TD, Li D. Effects of pre-gestational diabetes mellitus and gestational diabetes mellitus on macrosomia and birth defects in upstate New York. Diabetes Res Clin Pract. 2019;155:107811.